Rose Merc raises ₹15.7 cr from warrant conversion, equal to 37% of market cap
Four non-promoter investors converted warrants to inject cash into the nano-cap. The new capital is a major event relative to its size.
— 2 earlier stories on Rose Merc. Ltd. →What's new
- Rose Merc allotted 1,74,445 shares at ₹90 each to four investors upon warrant conversion.
- The ₹15.7 crore raise equals 37% of the company's ₹42 crore market capitalisation.
- Paid-up capital now stands at ₹6.42 crore, comprising 64,18,630 shares.
Why this matters
For a nano-cap, a cash infusion of this scale relative to its market value is a material equity event. The conversion sets a ₹90 price benchmark. The stated use of proceeds is vague, which means the next test is management's deployment of the capital.
What we're watching
- Whether Rose Merc specifies an acquisition or major expenditure for the ₹15.7 crore.
- If the ₹90 conversion price sets a floor in thin trading.
- Any further warrant conversions from the four investors.
The full read
Rose Merc just brought in ₹15.7 crore from four investors who converted warrants. The price: ₹90 a share. For a company with a ₹42 crore market cap, that cash equals 37% of its entire value. The dilution is a contained 2.8%. The money lands in a nano-cap where every crore matters. It strengthens the balance sheet but the filing offers no detail beyond 'general corporate purposes.' The open question is whether this cash funds an acquisition or simply supports the business. At ₹90, the investors have set a clear price benchmark for a stock that trades in thin volumes.
Questions answered
- Why is the ₹15.7 crore raise significant for Rose Merc?
- The amount equals 37% of the company's ₹42 crore market capitalisation. For a nano-cap, a cash infusion of this magnitude is a major event that materially alters the equity base.
- Who are the investors and what was the conversion price?
- The shares were allotted to four non-promoter investors: Amitkumar Yogendra Singh, Niti Trivedi, Vijay Acharya, and Vikas Kamlakar Phadnis. They paid ₹90 per share.
- How does the allotment change the company's capital structure?
- The allotment increased the total share count to 64,18,630 shares and the paid-up capital to ₹6.42 crore. The filing states this is a 2.8% dilution.
- What will the company do with the new funds?
- The filing states the proceeds are for 'general corporate purposes.' It does not specify any particular use, such as an acquisition, capital expenditure, or debt reduction.
Story so far
All notes on ROSEMER →- 5 Jun 2026 · 5:05 PM IST Rose Merc raises ₹15.7 cr from warrant conversion, equal to 37% of market cap
- 11d ago Rose Merc is paying 44% of its market cap for a slice of a US subsidiary
- 11d ago Rose Merc signs exploration pact with CATS Global for quantum, AI and defence tech